20332 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles Imidazole-alkanecarboxylic acids, e.g. histidine
Composition of chicken liver hydrolysates and method for improving alcohol metabolism, as well as preventing and treating liver fibrosis
#302Ameliorating agent for exercise-induced gastrointestinal disorders
#303CYCLOCREATINE MICROSUSPENSION
#304Tyrosinase activity inhibitor and external preparation for skin
#305LIQUID NUTRITIONAL FORMULA FOR TYROSINEMIA PATIENTS
#306Free amino acid preparation and uses thereof
#307NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE
#308Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#309Compositions and methods for managing digestive disorders and a healthy microbiome
#310Method of manufacturing VEGF antagonist fusion proteins
#311Aging inhibitor
#312IRE-1α inhibitors
#313Treatment for chronic kidney disease
#314Compositions and Methods for Treatment of Prediabetes
#315Infusion preparation
#316Methods and compositions for the sustained release of chromium
#3172-aminoethanol dihydrogen phosphate-based dietary supplement and synthesis process thereof
#318Methods for the safe administration of imidazole or imidazolium compounds
#319Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
#320Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#321DELIVERY MOLECULES FOR THERAPEUTICS
#322Microneedle device having a peptide therapeutic agent and an amino acid and methods of making and using the same
#323Methods and compositions for increasing the anaerobic working capacity in tissues
#324PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN AND AMINO ACIDS, PREPARATION METHODS AND USE THEREOF
#325Preparation method for antithyroid ointment for external application
#326Methods for improving muscle and heart function
#327Amino acid based diet with improved taste
#328COMPOSITIONS CONTAINING NITRIC OXIDE AMINO ACID ESTERS AND METHODS FOR IMPROVING SEXUAL PERFORMANCE
#329Compositions for administration of zoledronic acid or related compounds for treating lower back pain
#330Method for Medical Treatment
#331Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
#332NUTRITIONAL COMPOSITIONS
#333Production and use of bacterial histamine
#334Encapsulated active ingredients for controlled enteric release
#335Liquid nutritional formula for tyrosinemia patients
#336NUTRITION COMPOSITION SUPPRESSING GROWTH OF PROTOZOAN PARASITES OF BLOOD CELLS
#337NATURAL PRODUCT INHIBITORS OF 3DG
#338Methods and Diets to Protect Against Chemotoxicity and Age Related Illnesses
#339Method of inhibiting the glycation of nutrient and endogenous proteins and peroxidation of nutrient and endogenous lipids
#340METHODS OF AMELIORATING POST-DIALYSIS WASHOUT AND NUTRITIONAL SUPPLEMENTS FOR USE IN SUCH METHODS
#341Food containing histidine and use thereof
#342Anti-fatigue composition
#343Food Compositions Containing All Essential Nutrients
#344METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF SKIN DISORDERS
#345Peptides for skin rejuvenation and methods of using the same
#346PROTEIN-SPECIFIC FORMULATIONS
#347Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
#348Light-activated cation channel and uses thereof
#349VEGF specific fusion protein antagonist formulations
#350Polynucleotide compositions containing amino acids
#351Formulations Comprising Idebenone, N-Acetyl-S-Farnesyl-L-Cysteine and Ergothioneine and Uses Thereof
#352Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#353Amino Acid Composition for Use in the Treatment of a PDD
#354Stable VEGF antagonist formulations
#355Laser assisted wound healing protocol and system
#356Nutritional composition for improving brain function in phenylketonuria
#357Heat-stable dry powder pharmaceutical compositions and methods
#358COMPOSITIONS AND METHODS FOR THE PREPARATION OF KIDNEY PROTECTIVE AGENTS COMPRISING AMIFOSTINE AND AMINO ACIDS
#359SYNBIOTIC COMPOSITION FOR TREATMENT OF INFECTIONS IN ALLERGIC PATIENTS
#360Antiviral compounds and methods of use thereof
#361Methods and compositions for treating and preventing signs or symptoms of eye disease
#362Polymer composition and polymer material
#363Methods to inhibit infection during wound healing with topical compositions including amino acids
#364Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia
#365Implantable prosthetic device comprising a cell expressing a channelrhodopsin
#366Therapeutic compositions comprising imidazole and imidazolium compounds
#367Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation
#368Histidine and/or Histidine Derivative for the Treatment of Inflammatory Skin Diseases
#369USE OF ERGOTHIONEINE FOR INDUCING ACTIVITY OF NRF2 IN CELL
#370Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
#371NON-MUCOADHESIVE FILM DOSAGE FORMS
#372AQUEOUS LIQUID COMPOSITION INCLUDING HIGH CONCENTRATION OF L-HISTIDINE
#373PHARMACEUTICAL COMPOSITIONS INCORPORATING LOW-DOSE DRUGS
#374Therapeutic compositions comprising imidazole and imidazolium compounds
#375Methods and compositions for sustained release of chromium
#376Methods and compositions for the sustained release of chromium
#377Nutritional Composition for Gastrostomy-Tube Patients
#378HISTIDINYLATED CATIONIC AMPHIPHILES, PROCESS FOR PREPARATION THEROF AND THEIR LIPOSOMAL FORMULATION
#379Oral forms of a phosphonic acid derivative
#380Treatment for chronic kidney disease
#381Nutritional composition and method for improving heart failure
#382Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
#383Nitric Oxide Amino Acid Esters for Improving Vascular Circulation, and Prophylaxis or Treatment of a Condition Associated with Impaired Blood Circulation
#384Gluten-related disorders
#385Light-activated cation channel and uses thereof
#386ALLOSTERIC CHAPERONES AND USES THEREOF
#387IRE-1α inhibitors
#388Dietary Compositions and Methods for Protection Against Chemotherapy, Radiotherapy, Oxidative Stress, and Aging
#389Biomedical composition
#390Methods and compositions for treating and preventing signs or symptoms of eye disease
#391Stable liquid formulations of dimer VEGF antagonists
#392Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
#393Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
#394ANTI-TUMOR AQUEOUS SOLUTION, ANTI-CANCER AGENT, AND METHODS FOR PRODUCING SAID AQUEOUS SOLUTION AND SAID ANTI-CANCER AGENT
#395Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
#396Compositions prepared from poultry and methods of their use
#397NUTRITIONAL APPROACH TO THE USE OF ERGOTHIONEINE AND VITAMIN D2 FOR HAIR, NAIL AND SKIN GROWTH
#398Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
#399Use of amino acid supplementation for improved muscle recovery
#400HAIR CARE CONDITIONING COMPOSITION COMPRISING HISTIDINE
#401Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
#402Functionalized nanodiamonds as delivery platforms for nucleic acids
#403Covalently functionalized nanodiamond-based MALDI matrices and methods of use thereof
#404Carnosine hyaluronic acid mixtures and their use
#405Compositions and Methods for Improving Cardiovascular Health
#406METHODS AND USES OF CYTOCHROME P450 INHIBITORS
#407Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
#408Stem cell administration to reduce TNF-α level in CSF of an autism spectrum disorder or pervasive development disorder patient
#409Diagnosis, prognosis, and treatment of kidney disease
#410Methods and diets for lowering glucose and/or IGF-1 levels
#411Composition For Cosmetic And Health Improvement
#412Composition and method for treatment of symptoms associated with various skin conditions
#413Compositions comprising amino acids for prevention and/or treatment of renal disorders
#414PRODUCT FOR PARENTERAL NUTRITION OF OBESE INTENSIVE-CARE PATIENTS
#415Non-mucoadhesive film dosage forms
#416Medicinal skin protection composition with an active ingredient combination which improves the skin barrier
#417Cycloalkyl-substituted imidazole derivative
#418Use of L-Histidine and derivatives thereof
#419Amino-acid-containing composition for enhancing recovery from muscle fatigue
#420Methods and compositions for treating conditions related to lack of blood supply, shock, and neuronal injuries
#421L-HISTIDINE IN OPHTHALMIC SOLUTIONS
#422TIGHT JUNCTIONS MODULATORS
#423Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof
#424Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
#425TOPICAL MIXTURE AND METHOD FOR DERMAL APPLICATION TO REMOVE EXCESS IRON AND OTHER HEAVY METALS FROM CELLULAR TISSUE
#426Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents
#427Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
#428Injectable amino-acid composition
#429Stable liquid VEGF antagonist formulations
#430COMPOSITIONS COMPRISING AMINO ACIDS FOR PREVENTION AND/OR TREATMENT OF RENAL DISORDERS
#431Cycloalkyl-Substituted Imidazole Derivative
#432Light-activated cation channel and uses thereof
#433Stable formulations of rLP2086 antigens
#434Treatment of depressive disorders
#435PRODUCTION AND USE OF BACTERIAL HISTAMINE
#436Pharmaceutical composition for treating coagulation disorder hemorrhage and method using the same
#437IRE-1α inhibitors
#438Anti-aging formulations
#439USE OF CHROMIUM HISTIDINATE FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
#440Compositions comprising amino acids, with pro-angiogenic activity
#441Methods for identifying a GLP-1 secretagogue
#442Antimicrobial Compositions
#443Pharmaceutical composition for intracellar acidification with cis-urocanic acid
#444TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING
#445Cycloalkyl-substituted imidazole derivative
#446PRODUCTION AND USE OF BACTERIAL HISTAMINE
#447Product for parenteral nutrition of obese intensive-care patients
#448THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALPHA PRODUCTION INHIBITOR
#449Methods of reducing virulence in bacteria
#450COMPOSITION AND METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULES
#451Pharmaceutical composition for intracellular acidification with cis-urocanic acid
#452CONJUGATED PSYCHOTROPIC DRUGS AND USES THEREOF
#453ACTIVITY GENERATING DELIVERY MOLECULES
#454Method of increasing intratumoral pHe and reducing acid-mediated invasion
#455Methods of Treating Cognitive Dysfunction by Modulating Brain Energy Metabolism
#456NATURAL PRODUCT INHIBITORS OF 3DG
#457Agent and methods for reducing inflammatory markers
#458Laser enhanced amino acid blend and use of same to regenerate active myocardial tissue
#459Methods and compositions for increasing the anaerobic working capacity in tissues
#460METHODS AND USES OF CYTOCHROME P450 INHIBITORS
#461Oral forms of a phosphonic acid derivative
#462Stable liquid VEGF antagonist formulations
#463METHODS AND COMPOSITIONS USING ERGOTHIONEINE TO TREAT A VARIETY OF HEALTH RELATED FACTORS
#464Cell protection in dialysis patients by administration of a creatine compound
#465Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
#466COMPOSITION COMPRISING ALPHA-LIPOIC ACID AND CARNOSINE FOR TREATING THE PHANTOM LIMB SYNDROME
#467Methods and compositions for the sustained release of chromium
#468PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA
#469Dimer VEGF antagonist formulations
#470Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
#471COMPOSITIONS FOR REDUCING THE DELETERIOUS EFFECTS OF STRESS AND AGING
#472Resuscitation fluid
#473Resuscitation fluid
#474Promotion of healthy catch-up growth
#475FORMULATION FOR NAIL AND NAIL BED DISEASES
#476METHOD FOR TREATMENT OF PANCREATITIS
#477Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
#478Small molecule inhibitors of ghrelin O-acyltransferase
#479Amino acid compositions
#480Methods and compositions for increasing the anaerobic working capacity in tissues
#481Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
#482TREATMENT OF DEPRESSIVE DISORDERS
#483Nutrition composition
#484Wound care device having fluid transfer properties
#485High protein supplement
#486Methods to prevent and treat diseases
#487OPHTHALMIC SOLUTIONS, INCLUDING CONTACT LENS CARE AND EYE DROPS COMPRISING CARNOSINE, PREFERABLY IN COMBINATION WITH DEXPANTHENOL AND/OR HYALURONIC ACID
#488Use of Glutaric Acid Derivatives or the Pharmaceutically Acceptable Salts Thereof as Anti-Arrhythmic Agents
#489ADJUVANTING MATERIAL
#490Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions
#491Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract
#492Use of H3 Histaminergic Agonists for the Treatment of Addiction to Drugs of Abuse
#493Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
#494Amino acid composition for improving glucose tolerance
#495Wound care device having fluid transfer properties
#496Methods and compositions for increasing the anaerobic working capacity in tissues
#497Histidine and/or Histidine Derivative for the Treatment of Inflammatory Skin Diseases
#498VEGF antagonist formulations
#499Amino Acid-Containing Composition for Preventing or Remedying Decrease in the Skeletal Muscle of Aged People
#500ANTI-FATIGUE AGENT COMPRISING AMINO ACID COMPOSITION
#501PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF APTAMERS
#502Delivery of a light-activated cation channel into the brain of a subject
#503Self-Preserving Compositions
#504Conjugated psychotropic drugs and uses thereof
#505Preservation of ergothioneine
#506Stable Formulations of Peptides
#507Non-mucoadhesive film dosage forms
#508Anti A beta antibody formulation
#509METHODS AND COMPOSITIONS FOR ENHANCING COLLAGEN, PROTEOGLYCAN, AND GLUTATHIONE SYNTHESIS IN THE SKIN
#510Compositions and methods for the treatment of overactive bladder
#511ATHLETIC PATCH
#512AMINO ACID COMPOSITION
#513Therapy for the treatment of disease
#514PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA
#515Conjugated psychotropic drugs and uses thereof
#516Suppressant for cerebral infarction attributed to long-time ischemia
#517Small molecule inhibitors of ghrelin O-acyltransferase
#518Therapeutic agent for inflammatory bowel disease and TNF-α production inhibitor
#519NATURAL PRODUCT INHIBITORS OF 3DG
#520Conjugated psychotropic drugs and uses thereof
#521MEDICAL COMPOSITION FOR PROMOTION OF SKIN REGENERATION
#522Radiosensitizer Formulations and Methods for Use
#523THERAPY FOR DISORDERS OF THE PROXIMAL DIGESTIVE TRACT
#524Pharmaceutical formulation
#525USE OF CHROMIUM HISTIDINATE FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
#526Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
#527Therapy for the treatment of disease
#528Treatment methods employing histamine Hreceptor antagonists, including betahistine
#529Methods for identifying a GLP-1 secretagogue
#530THERAPY FOR THE TREATMENT OF DISEASE
#531INTRAOCULAR IRRIGATING SOLUTIONS AND METHODS FOR TREATING CORNEAL EDEMA
#532Peptide derivatives with therapeutic activity
#533Neuroprotective small organic molecules, compositions and uses of related thereto
#534Methods and compositions for treating feline hyperthyroidism
#535Compositions and methods for improving cardiovascular health
#536Use of compounds of formula A-R-Xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations
#537COMPOSITIONS COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF
#538METHOD FOR TREATMENT OF PANCREATITIS
#539Resuscitation fluid
#540Methods and compositions for the sustained release of chromium
#541Histidine derivatives
#542GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
#543Amino acid composition and supplementary liquid containing the same
#544Melanin eliminator preparation
#545Treatment of Depressive Disorders
#546PHARMACEUTICAL COMPOSITION COMPRISING A PROTON PUMP INHIBITOR AND PROTEIN COMPONENT
#547Methods for treatment of migraine and symptoms thereof
#548High protein supplement
#549Methods and compositions for increasing the anaerobic working capacity in tissues
#550Composition for a healthy gastrointestinal tract
#551USE OF GABA AND GABAB AGONISTS
#552Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
#553Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
#554Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
#555Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists
#556Methods and compositons for stimulating neurogenesis and inhibiting neuronal degeneration
#557Adjuvanting Material
#558INACTIVE ISOMER COMPOSITIONS FOR USE AS DRUG-RESISTANCE-REVERSAL AGENTS AND IN PROPHYLACTIC TREATMENT
#559METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR
#560Carnosine-related compounds for preventing and treating impaired neurovascular blood flow
#561DIETARY SUPPLEMENT COMPOSITION AND METHOD OF USE FOR THE TREATMENT AND PREVENTION OF OXIDATIVE STRESS
#562Treatment Of Stroke With Histamine H3 Inverse Agonists Or Histamine H3 Antagonists
#563IBUPROFEN COMPOSITION
#564THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALFA PRODUCTION INHIBITOR
#565Conjugated psychotropic drugs and uses thereof
#566Neuroprotectant methods, compositions, and screening methods thereof
#567PROPHYLACTIC/THERAPEUTIC AGENT FOR STRESS-INDUCED BOWEL DISEASE
#568Pharmaceutical combinations for the treatment of head-aches and migraine attacks as well as blisters and packs that contain them
#569Topical compositions containing solubilized allantoin and related methods
#570Use of branched chain fatty acid amino acid salts and compositions thereof
#571Nitroimidazole composition and method
#572Cerebral Infarction Suppressant
#573Composition and method to inhibit tissue plasminogen activator (tPA) - potentiated neurotoxicity
#574PROPHYLACTIC/THERAPEUTIC COMPOSITIONS FOR LIVER DISEASES
#575All day rhinitic condition treatment regimen
#576METHODS TO PREVENT AND TREAT DISEASES
#577Treatment of depressive disorders
#578Self-preserving composition
#579Material for Processed Food for Weight Reduction Diets and Weight Reduction Dietary Processed Food Using Thereof
#580Light-activated cation channel and uses thereof
#581Abnormal cannabidiols as agents for lowering intraocular pressure
#582Method for treating diseases with omega interferon
#583Formulation and method for a skin treatment for animals
#584PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA
#585Amino acid composition for improving glucose tolerance
#586COMPOSITION AND METHOD OF USE THEREOF
#587Certain chemical entities, compositions, and methods
#588METHOD OF TREATING INFLAMMATORY DISEASES
#589Conjugated psychotropic drugs and uses thereof
#590Imidazoyl-benzamide anti-cancer agents
#591Methods of treating and preventing Alzheimer's disease
#592Pharmaceutical Formulation
#593Compositions, methods and kits for removing debris from an ocular area
#594Pharmaceutical compositions for the administration of aptamers
#595L-HISTIDINE IN OPHTHALMIC SOLUTIONS
#596Conjugated psychotropic drugs and uses thereof
#597Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid
#598DRUGS FOR TREATING DIABETES
#599Composition Comprising Vitamin B12 and Acid Reducing Agent and Uses Thereof
#600Light-activated cation channel and uses thereof